Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00868660 · ClinicalTrials.gov registry record · Phase 1
Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose
A Phase 1 study, sponsored by Zealand Pharma.
- Completed
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT00868660 is a Phase 1 study that has completed, run by Zealand Pharma. The registered enrollment target is 66 participants.
The verdict
NCT00868660, a Phase 1 study, has completed, sponsored by Zealand Pharma.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
Healthy Normal Single Ascending Dose and Crohn's patient Multiple Ascending Dose
Interventions
- DRUG ZP1848
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00868660
The ClinicalTrials.gov registry entry for NCT00868660 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zealand Pharma, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ZP1848 is the first listed.
NCT00868660 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00868660 about?
NCT00868660 is a clinical study titled "Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose". Healthy Normal Single Ascending Dose and Crohn's patient Multiple Ascending Dose
What is the current status of trial NCT00868660?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2009-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00868660?
The interventions under investigation include: ZP1848 (DRUG).
Who is sponsoring clinical trial NCT00868660?
This trial is sponsored by Zealand Pharma, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.